Status:
COMPLETED
Risk-Adapted Treatment Strategies for Odontogenic Keratocysts: A Long-Term Randomized Clinical Trial Quantifying Recurrence Reduction
Lead Sponsor:
Qassim University
Collaborating Sponsors:
Al-Azhar University
Conditions:
Odontogenic Cysts
Eligibility:
All Genders
10+ years
Phase:
NA
Brief Summary
Background The odontogenic keratocysts (OKCs) have been one of the maxillofacial region's most contentious pathological phenomena. Decompression/marsupialization (D/M), enucleation (E), enucleation + ...
Detailed Description
Since the middle of the 20th century, the odontogenic keratocyst (OKC) has been one of the maxillofacial region's most contentious pathological phenomena. It was initially misdiagnosed as a primordial...
Eligibility Criteria
Inclusion
- All odontogenic keratocysts that are treated by the following surgical treatment modalities:
- Enucleation followed by peripheral ostectomy and Carnoy's solution
- Decompression/ marsupialization
- Enucleation
- Enucleation and Carnoy's solution
- Enucleation and Peripheral Ostectomy
- Follow-up period 10 years
Exclusion
- Cases treated with resection
- Cases showed neoplastic transformation in their pathology
- Cyst Like lesions
Key Trial Info
Start Date :
February 24 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2024
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06133764
Start Date
February 24 2023
End Date
December 31 2024
Last Update
January 7 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
College of Dentistry, Qassim University
Buraidah, Al-Qassim Region, Saudi Arabia, 1162